Location History:
- Gauting, DE (2022)
- Puchheim, DE (2023)
Company Filing History:
Years Active: 2022-2023
Title: Matthias Habjan: Innovator in Cancer Treatment
Introduction
Matthias Habjan is a prominent inventor based in Gauting, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical combinations. With a total of 2 patents, his work focuses on improving the survival rates of cancer patients.
Latest Patents
Habjan's latest patents include groundbreaking inventions aimed at treating cancer. The first patent, titled "Combination therapy for treating cancer with an antibody and intravenous administration of a recombinant MVA," relates to a pharmaceutical combination designed to reduce tumor volume and increase the survival of cancer patients. This combination involves the intravenous administration of a recombinant MVA encoding a tumor-associated antigen alongside an antibody treatment. The second patent, "Combination therapy for treating cancer with an intravenous administration of a recombinant MVA and an antibody," echoes similar themes, emphasizing the importance of this innovative approach in cancer therapy.
Career Highlights
Matthias Habjan is associated with Bavarian Nordic A/S, a company known for its focus on developing innovative cancer therapies. His work at the company has positioned him as a key player in the pharmaceutical industry, particularly in the realm of oncology.
Collaborations
Throughout his career, Habjan has collaborated with notable colleagues, including Hubertus Hochrein and Henning Lauterbach. These partnerships have further enhanced his research and contributed to the advancement of cancer treatment methodologies.
Conclusion
Matthias Habjan's contributions to cancer treatment through his innovative patents and collaborations highlight his commitment to improving patient outcomes. His work continues to pave the way for advancements in the pharmaceutical industry.